Cabilinga, Samuel E.
HRN: 18-30-21 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
10/17/2023
10/23/2023
IV
1.5g
Q6h
Cap Mr
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes